- Home
- AIRT vs NVNO Comparison
AIRT vs NVNO Comparison
Compare AIRT & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRT
- NVNO
- Stock Information
- Founded
- AIRT 1980
- NVNO 1987
- Country
- AIRT United States
- NVNO United States
- Employees
- AIRT N/A
- NVNO N/A
- Industry
- AIRT Air Freight/Delivery Services
- NVNO Medical/Dental Instruments
- Sector
- AIRT Consumer Discretionary
- NVNO Health Care
- Exchange
- AIRT Nasdaq
- NVNO Nasdaq
- Market Cap
- AIRT 54.3M
- NVNO 55.2M
- IPO Year
- AIRT N/A
- NVNO N/A
- Fundamental
- Price
- AIRT $20.20
- NVNO $3.29
- Analyst Decision
- AIRT
- NVNO
- Analyst Count
- AIRT 0
- NVNO 0
- Target Price
- AIRT N/A
- NVNO N/A
- AVG Volume (30 Days)
- AIRT 14.1K
- NVNO 202.2K
- Earning Date
- AIRT 02-10-2025
- NVNO 02-27-2025
- Dividend Yield
- AIRT N/A
- NVNO N/A
- EPS Growth
- AIRT N/A
- NVNO N/A
- EPS
- AIRT N/A
- NVNO N/A
- Revenue
- AIRT $284,091,000.00
- NVNO N/A
- Revenue This Year
- AIRT N/A
- NVNO N/A
- Revenue Next Year
- AIRT N/A
- NVNO N/A
- P/E Ratio
- AIRT N/A
- NVNO N/A
- Revenue Growth
- AIRT N/A
- NVNO N/A
- 52 Week Low
- AIRT $14.02
- NVNO $2.45
- 52 Week High
- AIRT $30.60
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- AIRT 51.54
- NVNO 56.55
- Support Level
- AIRT $18.85
- NVNO $3.13
- Resistance Level
- AIRT $20.51
- NVNO $3.26
- Average True Range (ATR)
- AIRT 0.71
- NVNO 0.22
- MACD
- AIRT -0.07
- NVNO 0.02
- Stochastic Oscillator
- AIRT 66.83
- NVNO 47.33
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).